Cargando…
Aberrant Promoter Hypomethylation of Sortilin 1: A Moyamoya Disease Biomarker
BACKGROUND AND PURPOSE: The pathogenesis of moyamoya disease (MMD) remains poorly understood, and no reliable molecular biomarkers for MMD have been identified to date. The present study aimed to identify epigenetic biomarkers for use in the diagnosis of MMD. METHODS: We performed integrated analyse...
Autores principales: | Sung, Hye Youn, Lee, Ji Yeoun, Park, Ae Kyung, Moon, Youn Joo, Jo, Inho, Park, Eun-Mi, Wang, Kyu-Chang, Phi, Ji Hoon, Ahn, Jung-Hyuck, Kim, Seung-Ki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Stroke Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186926/ https://www.ncbi.nlm.nih.gov/pubmed/30309230 http://dx.doi.org/10.5853/jos.2018.00962 |
Ejemplares similares
-
Moyamoya Syndrome: A Window of Moyamoya Disease
por: Phi, Ji Hoon, et al.
Publicado: (2015) -
Aberrant Hypomethylation of Solute Carrier Family 6 Member 12 Promoter Induces Metastasis of Ovarian Cancer
por: Sung, Hye Youn, et al.
Publicado: (2017) -
Posterior Cerebral Artery Insufficiency in Pediatric Moyamoya Disease
por: Lee, Ji Yeoun, et al.
Publicado: (2015) -
Chemokine Ligand 5 (CCL5) Derived from Endothelial Colony-Forming Cells (ECFCs) Mediates Recruitment of Smooth Muscle Progenitor Cells (SPCs) toward Critical Vascular Locations in Moyamoya Disease
por: Phi, Ji Hoon, et al.
Publicado: (2017) -
Indirect revascularization surgery for moyamoya disease in children and its special considerations
por: Wang, Kyu-Chang, et al.
Publicado: (2012)